Status:

ACTIVE_NOT_RECRUITING

Supplement Combination on Stress and Sleep

Lead Sponsor:

University of South Carolina

Collaborating Sponsors:

Momentous

Conditions:

Healthy

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Eligibility Criteria

Inclusion

  • Healthy participants aged 18 to 50 years (inclusive) at the time of screening with a body mass index of 18.5 to 29.9 kg/m2.
  • Willing to give voluntary consent, be able to understand and read the questionnaires, carry out all study-related procedures, communicate effectively with the study staff, and agree to allow any study-related evaluations.
  • Participant is physically active: participating in resistance and/or endurance exercise ≥150 min/wk for ≥6 mo.
  • Participant will be asked about dietary supplementation use within the past 6 months.
  • If participant began taking a supplement within the past month, participant will be asked to discontinue supplement use followed by a 2-week washout prior to participation.In all other cases, supplement use will be asked to be maintained throughout the study.
  • • The participant has an apple device with iOS 16 or greater software.

Exclusion

  • Have a known sensitivity of allergy to any of the investigational products.
  • Participants currently taking any of the investigational products will be excluded.
  • Female participants who are lactating, pregnant, or planning to become pregnant during the study.
  • Diagnosed with any sleep-related or stress-related disorders.
  • Currently taking medication to manage sleep or cortisol levels.
  • Participants with controlled or uncontrolled hypertension including stage 1 hypertension (systolic blood pressure ≥129 mmHg and diastolic blood pressure ≥89 mmHg).
  • Any other condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data.

Key Trial Info

Start Date :

February 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2025

Estimated Enrollment :

115 Patients enrolled

Trial Details

Trial ID

NCT06889584

Start Date

February 15 2025

End Date

October 1 2025

Last Update

August 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of South Carolina Sport Science Lab

Columbia, South Carolina, United States, 29208